TM
ZBIO

Torren Management’s Zenas BioPharma ZBIO Stock Holding History

Torren Management’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41K Hold
95
– – ﹤0.01% 517
2026
Q1 		$1.86K Hold
95
– – ﹤0.01% 580
2025
Q4 		$3.45K Buy
+95
New +$3.12K ﹤0.01% 972

Other funds holding ZBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Torren Management's ZBIO Position: Q2 2026 in Review

Torren Management held its Zenas BioPharma (ZBIO) position steady in Q2 2026 at 95 shares worth $2.41K. The position accounts for ﹤0.01% of the portfolio, ranked #517.

Torren Management first reported a position in ZBIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.45K in Q4 2025. 38 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • Torren Management held 95 shares of Zenas BioPharma worth $2.41K as of Q2 2026.
  • Torren Management left its Zenas BioPharma share count unchanged in Q2 2026.
  • Zenas BioPharma made up ﹤0.01% of Torren Management's portfolio in Q2 2026, its #517 holding.
  • Torren Management first reported a position in Zenas BioPharma in Q4 2025 and has held it in 3 quarters since.
  • Torren Management's Zenas BioPharma position peaked at $3.45K in Q4 2025.
  • 38 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Torren Management's 13F filing for Q2 2026, filed 10 Jul 2026.